Scholars Central

OpinionPublished 31 Mar 2023

Evaluating the Sensitivity of HL-ICOs to Hepatotoxicants: Implications for In Vitro Toxicity Assessment

Authors: John Simpson

Journal of Drug Metabolism & Toxicology

Volume 14 · Issue 1 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

New developments in in vitro toxicity testing make an effort to address the demand for trustworthy human-based safety evaluation in medication development. The term "Intrahepatic Cholangiocyte Organoids" (ICOs) refers to an in vitro disease model for regenerative medicine that is developed from a donor. Here, we investigated the expression and activity of genes implicated in drug metabolism, a significant factor in druginduced toxicity, and the exposure of Hepatocyte-like ICOs (HLICOs) to well-known hepatotoxicants in order to examine the potential of HL-ICOs in in vitro toxicity testing. In terms of CYP3A4 expression, HL-ICOs' drug metabolism was equivalent to that of Preventive Health and Health services (PHHs) and HepaRGs, while other enzymes, such CYP2B6 and CYP2D6, were expressed at lower levels. EC50 values for acetaminophen were also calculated in HL-ICOs (24.0–26.8 mM) Troglitazone (23.1-90.8 M), diclofenac (475.5–500 M), perhexiline (9.7–31.5 M), and valproic acid (>10 mM). When exposed to the hepatotoxicants, HL-ICOs had EC50s that were equivalent to those of PHHs and HepaRGs, although they were less susceptible to acetaminophen. For the purpose of correctly defining the potential of HL-ICOs in in vitro toxicity assessment, more understanding of enzyme and transporter activities in drug metabolism in HL-ICOs and exposure to a larger chemical collection are required.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Drug Metabolism & Toxicology
  • SubjectDiabetes & Endocrinology
  • SubjectPharmaceutical Sciences
  • SubjectToxicology
  • BylineArticles whose byline prints “John Simpson”